Covered recipient · General Payments record
AMIR BAHARLOO
Podiatric Medicine & Surgery Service Providers Podiatrist Foot & Ankle Surgery
General Payments · PY2023
$405.37
- Reported across 17 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $391.32 | 16 |
| Travel and Lodging | $14.05 | 1 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $204.31 | 9 |
| ACUMED LLC | $88.46 | 2 |
| Bioventus LLC | $47.41 | 2 |
| Integra LifeSciences Corporation | $34.22 | 2 |
| Smith & Nephew, Inc. | $16.92 | 1 |
| Musculoskeletal Transplant Foundation Inc. | $14.05 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2023 | $405.37 | 17 |
Payment records · PY2023 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | $27.78 | 01/19/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996189647 | CMS |
| AbbVie Inc. | $26.31 | 03/04/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996189649 | CMS |
| AbbVie Inc. | $19.96 | 04/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996189651 | CMS |
| AbbVie Inc. | $24.73 | 05/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996189653 | CMS |
| AbbVie Inc. | $20.37 | 06/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996189655 | CMS |
| AbbVie Inc. | $19.59 | 07/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996189657 | CMS |
| AbbVie Inc. | $20.74 | 09/28/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996189659 | CMS |
| AbbVie Inc. | $17.39 | 11/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996189661 | CMS |
| AbbVie Inc. | $27.44 | 12/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996189663 | CMS |
| ACUMED LLC | $32.91 | 02/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1040402329 | CMS |
| ACUMED LLC | $55.55 | 05/31/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1040402319 | CMS |
| Bioventus LLC | $31.76 | 02/03/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1026703721 | CMS |
| Bioventus LLC | $15.65 | 05/05/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1026703787 | CMS |
| Integra LifeSciences Corporation | $21.26 | 05/19/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031520153 | CMS |
| Integra LifeSciences Corporation | $12.96 | 06/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031520147 | CMS |
| Musculoskeletal Transplant Foundation Inc. | $14.05 | 06/07/2023 | Travel and Lodging | Undisputed | 01/23/2026 | 1050906365 | CMS |
| Smith+Nephew, Inc. | $16.92 | 02/15/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1053369447 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023
- Source files
- Dataset page · Bulk file · PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.